Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,161.00
-17.00 (-1.44%)
Jul 30, 2025, 2:26 PM IDT
-1.44%
Market Cap134.46M
Revenue (ttm)308.19M
Net Income (ttm)2.60M
Shares Out11.41M
EPS (ttm)0.22
PE Ratio53.30
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume272
Average Volume3,240
Open1,178.00
Previous Close1,178.00
Day's Range1,161.00 - 1,178.00
52-Week Range1,130.00 - 1,601.00
Beta0.09
RSI37.33
Earnings DateAug 27, 2025

About TLV:REKA

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise generic Rx and OTC drugs used in various therapeutic fields, such as urinary tract pain, steroid anti-in... [Read more]

Sector Healthcare
Founded 1947
Employees 421
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol REKA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.